摘要
植入前遗传学诊断(PGD)是在胚胎植入子宫前进行遗传学检查的新技术。它可对植入胚胎进行性别选择,从而引发了会增加我国出生人口性别比的担忧。通过对PGD性别选择伦理风险的分析,指出其用于医学需要时不会对性别比造成危害。但在实施过程中需要医生、患者及社会全体人员共同参与,避免该技术用于非医学目的的需要。
Pre-implantation genetic diagnosis （ PGD） is a new technology of genetic testing that is performed before the embryos being implanted into the womb. PGD might be used for gender selection, which incurs a concern about whether it intensifies our country＇ s imbalance in sexual ratio. Through the ethical analysis to the PGD related gender selection, we found the sexual ratio will not be endangered when it is applied for medical scientific need. Moreover, in the actual implementation process, doctors, patients and other participants should get together to avoid this technology being used for non -medical scientific need.
出处
《医学与哲学（A）》
CSSCI
北大核心
2008年第10期13-15,共3页
Medicine & Philosophy:Humanistic & Social Medicine Edition
关键词
植入前遗传学诊断
性别选择
人口性别比
伦理辩护
男性偏好
pre-implantation genetic diagnosis, gender selection, sexual ratio, ethical defense, male preference
